The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
about
Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesisCrystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolutionSecreted cathepsin L generates endostatin from collagen XVIIIAntiangiogenic gene therapy of cancer: recent developmentsPrinciples of the prolactin/vasoinhibin axisThe role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor.Expression and characterization of novel ovine orthologs of bovine placental prolactin-related proteins.Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions.Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin.Angiogenesis in epithelian ovarian cancer.N-terminal prolactin-derived fragments, vasoinhibins, are proapoptoptic and antiproliferative in the anterior pituitary.The role of angiogenesis in rheumatoid arthritis: recent developmentsActivation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo.Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress.What can we learn from rodents about prolactin in humans?Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.Cellular actions and signaling by endostatin.The role of prolactin in mammary carcinoma.Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.Angiogenesis as a target in rheumatoid arthritis.The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactinTumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growthThe mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.Vasoinhibins: novel inhibitors of ocular angiogenesis.Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors.Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?Analysis of site-specific histidine protonation in human prolactinAngiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest.Antiangiogenic therapy of transgenic mice impairs de novo tumor growthVasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation.The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.Tumour vasculature--a potential therapeutic target.A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo.The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype.
P2860
Q21328694-55B29D47-78D1-4116-A95C-8512C44F4310Q24533185-F8307C8B-91A4-4D24-BD58-F10DA9C252A3Q24599981-E3746278-C0DB-4176-9ACC-AF03BE97F8BEQ24803786-C46D0089-9560-4CCD-B0D4-86854D6B4452Q26796671-6FFAEC5F-6A47-4B73-A7C9-71F58CFFA5A7Q30251689-5589B501-839C-4D94-A240-EA82123F0673Q33286692-507884D4-A124-4979-AEC6-5975EAAC7ABAQ33303914-CC61AF73-D51E-453E-A246-8DFC54247CA2Q33632082-E51EEFD2-4E5A-4F75-8EFF-52234297776BQ33861490-6447F980-2060-40EF-B0AE-6543824CB466Q33889173-A152C6BA-C7D0-4EB6-8B36-093D8C17F5FEQ33919078-18B84954-8350-412B-BA87-8C6BF9D8E7D7Q33961535-2C9242F2-63B5-4E0E-9D16-7EC258CDBEDBQ34071300-C8D67354-7913-44F3-8DFA-3B4B28DDF6CAQ34121190-F5FD4D6C-59B4-4E9E-9FD4-F1C10DB4E708Q34346132-D325CEC4-C572-4526-8DD3-F15C089EA3F2Q34368742-ED0E5A53-A5E5-48C4-8B7B-6093832CF0CBQ34721567-1295AFC7-555B-460D-8A0A-1CEAC2757923Q34985976-B9D472FE-FB45-46FB-BA25-9023C27EB0A7Q35008096-8D6550D4-FFD8-4F23-AD01-48160F17BC5DQ35067253-12F6867D-859B-409C-AFDE-0317C7832448Q35080616-8FE8FB0B-5CDC-46A2-BE1E-75C6152C3781Q35193397-F3D57017-49F5-4DC0-8C3A-AD32358FB336Q35553507-F2BBCF63-0125-4983-80A6-5767599CAA18Q35851969-F1283A46-8185-49CC-959D-64BBA761B1A6Q36167792-357AA1B5-6861-4016-AE15-C89DF2F89F84Q36335626-B687803B-6E26-4021-A7AD-F52AC99E16FDQ36401336-71B7598D-B6D3-4E7A-AD08-BF71DD6B3CFFQ36598768-43DF7E0F-E9F8-468B-BE42-5C8C425E9A2BQ37188138-60A53731-EC5A-45FD-8ADA-83BC9A3CB795Q37262654-3DF7DE69-7134-4206-AC5D-A4B616053564Q37294904-84342A8C-24AD-425B-B4A9-EEAA28014B1FQ37397564-41AA79DE-7D06-4FA2-AF05-EB6EDCD6C92CQ37407741-7402B757-04FC-4161-AB0C-908498B76D65Q37707900-ECA88E79-E46F-4F40-9A04-9B4484E897A6Q38572150-C6259440-A9E9-492C-A8E0-038D91D79826Q38974193-D9BCF58F-0B96-4A15-B988-59DE1BACF2F1Q40403280-C369E93A-13DE-4387-B97A-7B63B1A6227FQ40744489-43FA0BB5-86A0-4F70-A726-AD5BD7A2484CQ40865269-FCF357D2-4451-49B2-9C6B-43D6A4672495
P2860
The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The 16-kilodalton N-terminal f ...... ent inhibitor of angiogenesis.
@en
The 16-kilodalton N-terminal f ...... ent inhibitor of angiogenesis.
@nl
type
label
The 16-kilodalton N-terminal f ...... ent inhibitor of angiogenesis.
@en
The 16-kilodalton N-terminal f ...... ent inhibitor of angiogenesis.
@nl
prefLabel
The 16-kilodalton N-terminal f ...... ent inhibitor of angiogenesis.
@en
The 16-kilodalton N-terminal f ...... ent inhibitor of angiogenesis.
@nl
P2093
P1433
P1476
The 16-kilodalton N-terminal f ...... ent inhibitor of angiogenesis.
@en
P2093
Martial JA
Rentier-Delure F
P304
P356
10.1210/ENDO.133.3.7689950
P407
P577
1993-09-01T00:00:00Z